Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
DXAI4F
|
||||
Drug Name |
(E)-3-Biphenyl-4-yl-N-{2-[3-(2,3-dimethyl-phenylsulfamoyl)-phenylcarbamoyl]-ethyl}-acrylamide
|
||||
Synonyms |
CHEMBL423158
|
||||
Indication | Discovery agent | Investigative | [1587926] | ||
Formula |
C32H31N3O4S
|
||||
Canonical SMILES |
Cc1cccc(NS(=O)(=O)c2cccc(NC(=O)CCNC(=O)\\C=C\\c3ccc(cc3)c4ccccc4)c2)c1C
|
||||
InChI |
InChI=1S/C32H31N3O4S/c1-23-8-6-13-30(24(23)2)35-40(38,39)29-12-7-11-28(22-29)34-32(37)20-21-33-31(36)19-16-25-14-17-27(18-15-25)26-9-4-3-5-10-26/h3-19,22,35H,20-21H2,1-2H3,(H,33,36)(H,34,37)/b19-16+
|
||||
InChIKey |
WMWCULCOCZVXGF-KNTRCKAVSA-N
|
||||
Target and Pathway | |||||
Target(s) | Farnesyltransferase | Target Info | [1587926] | ||
Protein farnesyltransferase beta subunit | Target Info | [1587926] | |||
NetPath Pathway | TSH Signaling Pathway | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.